SPADEL SA (SPA.BR) Stock Fundamental Analysis

EBR:SPA • BE0003798155

260 EUR
0 (0%)
Last: Feb 17, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, SPA scores 5 out of 10 in our fundamental rating. SPA was compared to 30 industry peers in the Beverages industry. SPA gets an excellent profitability rating and is at the same time showing great financial health properties. SPA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • SPA had positive earnings in the past year.
  • In the past year SPA had a positive cash flow from operations.
  • SPA had positive earnings in each of the past 5 years.
  • In the past 5 years SPA always reported a positive cash flow from operatings.
SPA.BR Yearly Net Income VS EBIT VS OCF VS FCFSPA.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

  • The Return On Assets of SPA (8.70%) is better than 93.33% of its industry peers.
  • SPA has a better Return On Equity (13.47%) than 73.33% of its industry peers.
  • SPA has a better Return On Invested Capital (11.79%) than 83.33% of its industry peers.
  • SPA had an Average Return On Invested Capital over the past 3 years of 8.57%. This is in line with the industry average of 7.64%.
  • The 3 year average ROIC (8.57%) for SPA is below the current ROIC(11.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.7%
ROE 13.47%
ROIC 11.79%
ROA(3y)6.19%
ROA(5y)6.45%
ROE(3y)9.43%
ROE(5y)10.16%
ROIC(3y)8.57%
ROIC(5y)9.02%
SPA.BR Yearly ROA, ROE, ROICSPA.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • SPA has a better Profit Margin (10.90%) than 66.67% of its industry peers.
  • SPA's Profit Margin has improved in the last couple of years.
  • SPA has a worse Operating Margin (13.14%) than 66.67% of its industry peers.
  • SPA's Operating Margin has improved in the last couple of years.
  • SPA's Gross Margin of 39.57% is on the low side compared to the rest of the industry. SPA is outperformed by 70.00% of its industry peers.
  • In the last couple of years the Gross Margin of SPA has remained more or less at the same level.
Industry RankSector Rank
OM 13.14%
PM (TTM) 10.9%
GM 39.57%
OM growth 3Y-0.5%
OM growth 5Y1.58%
PM growth 3Y4.62%
PM growth 5Y3.65%
GM growth 3Y1.4%
GM growth 5Y1.36%
SPA.BR Yearly Profit, Operating, Gross MarginsSPA.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SPA is creating some value.
  • SPA has about the same amout of shares outstanding than it did 1 year ago.
  • SPA has about the same amout of shares outstanding than it did 5 years ago.
  • SPA has a worse debt/assets ratio than last year.
SPA.BR Yearly Shares OutstandingSPA.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
SPA.BR Yearly Total Debt VS Total AssetsSPA.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 5.98 indicates that SPA is not in any danger for bankruptcy at the moment.
  • SPA has a better Altman-Z score (5.98) than 100.00% of its industry peers.
  • SPA has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.13, SPA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that SPA is not too dependend on debt financing.
  • SPA has a better Debt to Equity ratio (0.01) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 5.98
ROIC/WACC1.48
WACC7.98%
SPA.BR Yearly LT Debt VS Equity VS FCFSPA.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.88 indicates that SPA should not have too much problems paying its short term obligations.
  • SPA has a better Current ratio (1.88) than 73.33% of its industry peers.
  • A Quick Ratio of 1.70 indicates that SPA should not have too much problems paying its short term obligations.
  • The Quick ratio of SPA (1.70) is better than 96.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.7
SPA.BR Yearly Current Assets VS Current LiabilitesSPA.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • SPA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.61%, which is quite impressive.
  • SPA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.75% yearly.
  • Looking at the last year, SPA shows a quite strong growth in Revenue. The Revenue has grown by 11.40% in the last year.
  • The Revenue has been growing slightly by 4.92% on average over the past years.
EPS 1Y (TTM)26.61%
EPS 3Y15.47%
EPS 5Y8.75%
EPS Q2Q%10.68%
Revenue 1Y (TTM)11.4%
Revenue growth 3Y10.37%
Revenue growth 5Y4.92%
Sales Q2Q%10.81%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPA.BR Yearly Revenue VS EstimatesSPA.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.74 indicates a rather expensive valuation of SPA.
  • Compared to the rest of the industry, the Price/Earnings ratio of SPA is on the same level as its industry peers.
  • SPA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.99.
Industry RankSector Rank
PE 24.74
Fwd PE N/A
SPA.BR Price Earnings VS Forward Price EarningsSPA.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as SPA.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SPA indicates a slightly more expensive valuation: SPA is more expensive than 70.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 27.17
EV/EBITDA 12.5
SPA.BR Per share dataSPA.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The decent profitability rating of SPA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.83
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • SPA has a yearly dividend return of 0.86%, which is pretty low.
  • Compared to an average industry Dividend Yield of 2.30, SPA is paying slightly less dividend.
  • With a Dividend Yield of 0.86, SPA pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.86%

5.2 History

  • The dividend of SPA has a limited annual growth rate of 1.92%.
Dividend Growth(5Y)1.92%
Div Incr Years2
Div Non Decr Years2
SPA.BR Yearly Dividends per shareSPA.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 30.45% of the earnings are spent on dividend by SPA. This is a low number and sustainable payout ratio.
  • SPA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP30.45%
EPS Next 2YN/A
EPS Next 3YN/A
SPA.BR Yearly Income VS Free CF VS DividendSPA.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SPA.BR Dividend Payout.SPA.BR Dividend Payout, showing the Payout Ratio.SPA.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SPADEL SA

EBR:SPA (2/17/2026, 7:00:00 PM)

260

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)09-01
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners97.59%
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)399.96M
Net Income(TTM)43.62M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.86%
Yearly Dividend2.2
Dividend Growth(5Y)1.92%
DP30.45%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 24.74
Fwd PE N/A
P/S 2.7
P/FCF 27.17
P/OCF 15.73
P/B 3.33
P/tB 5.06
EV/EBITDA 12.5
EPS(TTM)10.51
EY4.04%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.57
FCFY3.68%
OCF(TTM)16.53
OCFY6.36%
SpS96.38
BVpS78.04
TBVpS51.43
PEG (NY)N/A
PEG (5Y)2.83
Graham Number135.85
Profitability
Industry RankSector Rank
ROA 8.7%
ROE 13.47%
ROCE 14.63%
ROIC 11.79%
ROICexc 19.37%
ROICexgc 39.13%
OM 13.14%
PM (TTM) 10.9%
GM 39.57%
FCFM 9.93%
ROA(3y)6.19%
ROA(5y)6.45%
ROE(3y)9.43%
ROE(5y)10.16%
ROIC(3y)8.57%
ROIC(5y)9.02%
ROICexc(3y)13.94%
ROICexc(5y)13.81%
ROICexgc(3y)32.94%
ROICexgc(5y)32.52%
ROCE(3y)10.63%
ROCE(5y)11.39%
ROICexgc growth 3Y14.92%
ROICexgc growth 5Y8.53%
ROICexc growth 3Y13.66%
ROICexc growth 5Y8.37%
OM growth 3Y-0.5%
OM growth 5Y1.58%
PM growth 3Y4.62%
PM growth 5Y3.65%
GM growth 3Y1.4%
GM growth 5Y1.36%
F-Score8
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Debt/EBITDA 0.04
Cap/Depr 125.99%
Cap/Sales 7.22%
Interest Coverage 73.39
Cash Conversion 90.89%
Profit Quality 91.05%
Current Ratio 1.88
Quick Ratio 1.7
Altman-Z 5.98
F-Score8
WACC7.98%
ROIC/WACC1.48
Cap/Depr(3y)93.53%
Cap/Depr(5y)93.22%
Cap/Sales(3y)5.83%
Cap/Sales(5y)6.29%
Profit Quality(3y)136.29%
Profit Quality(5y)124.06%
High Growth Momentum
Growth
EPS 1Y (TTM)26.61%
EPS 3Y15.47%
EPS 5Y8.75%
EPS Q2Q%10.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.4%
Revenue growth 3Y10.37%
Revenue growth 5Y4.92%
Sales Q2Q%10.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.43%
EBIT growth 3Y9.82%
EBIT growth 5Y6.57%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.09%
FCF growth 3Y16.51%
FCF growth 5Y18.57%
OCF growth 1Y85.3%
OCF growth 3Y13.89%
OCF growth 5Y11.4%

SPADEL SA / SPA.BR FAQ

What is the ChartMill fundamental rating of SPADEL SA (SPA.BR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to SPA.BR.


What is the valuation status of SPADEL SA (SPA.BR) stock?

ChartMill assigns a valuation rating of 1 / 10 to SPADEL SA (SPA.BR). This can be considered as Overvalued.


Can you provide the profitability details for SPADEL SA?

SPADEL SA (SPA.BR) has a profitability rating of 7 / 10.


How financially healthy is SPADEL SA?

The financial health rating of SPADEL SA (SPA.BR) is 7 / 10.


How sustainable is the dividend of SPADEL SA (SPA.BR) stock?

The dividend rating of SPADEL SA (SPA.BR) is 3 / 10 and the dividend payout ratio is 30.45%.